$Removal: “Severe refractory colitis after intraperitoneal infusion of CEA-directed CAR T cells in patients with colorectal cancer”$

Removal: “Severe refractory colitis after intraperitoneal infusion of CEA-directed CAR T cells in patients with colorectal cancer”

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	SAGE Publishing 2025-07-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/17588359251345270
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Removal: “Severe refractory colitis after intraperitoneal infusion of CEA-directed CAR T cells in patients with colorectal cancer”
by: Kexin Ye, et al.
Published: (2024-12-01)

Intraperitoneal infusion of mesenchymal stem cell attenuates severity of collagen antibody induced arthritis.
by: Yoojun Nam, et al.
Published: (2018-01-01)

The Significance and Diagnostic Potential of CEA and FIB in Colorectal Cancer
by: Lin Zhu, et al.
Published: (2025-03-01)

Intraperitoneal insulin infusion: on the way to the artificial pancreas
by: Vladimir Aleksandrovich Karpel'ev, et al.
Published: (2015-10-01)

Be cautious to adopt a second CAR T-cell infusion after failure of CD19/CD22 cocktail CAR T-cell therapy in relapsed/refractory B-NHL
by: Gaoxiang Wang, et al.
Published: (2025-03-01)

Intraperitoneal Infusion of Mesenchymal Stem/Stromal Cells Prevents Experimental Autoimmune Uveitis in Mice
by: Joo Youn Oh, et al.
Published: (2014-01-01)

Prognostic value of preoperative and postoperative serum CEA in colorectal signet ring cell carcinoma
by: Yanan Zheng, et al.
Published: (2025-03-01)

CEA vaccines
by: Anchit Bhagat, et al.
Published: (2023-12-01)

Three timepoint perioperative CEA levels are a prognostic factor for recurrence after adjuvant chemotherapy in patients with Stage II and III colorectal cancer
by: Shodai Mizuno, et al.
Published: (2025-05-01)

Intraperitoneal Administration of S100A8 Ameliorates Experimental Acute Colitis in Rats
by: Kano Matsuo, et al.
Published: (2024-11-01)

The effects of two combined methods of P53 expression and preoperative serum CEA detection on the prognosis of colorectal cancer
by: Guojun Tong, et al.
Published: (2025-07-01)

Effect of intraperitoneal hyperthermic perfusion chemotherapy after laparoscopic surgery for colorectal cancer and the changes in the HMGB1 and RAGE level
by: LIANG Qizheng，FAN Yue，FU Yang，LI Guodong
Published: (2025-07-01)

CD19-Directed CAR T Cells Treatment in a Patient with Refractory DLBCL and CNS Involvement
by: Antonia Maria S. Müller, et al.
Published: (2019-09-01)

Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy
by: Eric Aniogo, et al.
Published: (2024-12-01)

The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
by: Bethany Shinkins, et al.
Published: (2017-01-01)

Analysis of the prognostic survival of Ki67, CEA, CA199 and relevant clinical pathological features in metastatic colorectal cancer
by: Huang Jian, et al.
Published: (2023-06-01)

Effectiveness of Factor XIII Infusion in Treatment of Refractory Ureteral Leakage after Kidney Transplantation
by: Ryoichi Maenosono, et al.
Published: (2020-01-01)

Engineering and targeting potential of CAR NK cells in colorectal cancer
by: Muhammad Babar Khawar, et al.
Published: (2025-07-01)

Filgotinib to Treat Acute Severe Refractory Ulcerative Colitis: A Case Report and Review of the Literature
by: Giuliana Vespere, et al.
Published: (2025-04-01)

CEA 重组痘苗病毒免疫巨噬细胞抑制CEA 阳性肿瘤的机制
by: 赵　青, et al.
Published: (2000-01-01)

Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Youngbae Jeon, et al.
Published: (2023-12-01)

Increased Risk of Colorectal Cancer in Ulcerative Colitis Patients Diagnosed after 40 Years of Age
by: Constantine J Karvellas, et al.
Published: (2007-01-01)

Short- and longevity outcome of cyclosporin rescue therapy in severe ulcerative colitis refractory to intravenous corticosteroid treatment
by: Bernadett Farkas, et al.
Published: (2025-08-01)

Cytoreductive surgery and hyperthermal intraperitoneal chemoperfusion in colorectal cancer and cancer of ovaries: our experience and perspectives of a new method
by: A. V. Malynovskyi, et al.
Published: (2020-10-01)

Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma
by: Johannes M. Waldschmidt, et al.
Published: (2025-03-01)

Laparoscopic two-stage operation for rectal cancer with refractory obstructive colitis after kidney transplantation: a case report
by: Atsuro Fujinaga, et al.
Published: (2020-02-01)

Robotisation of cavity string assembly at CEA
by: Drant Julien, et al.
Published: (2024-01-01)

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma
by: Evgenii Shumilov, et al.
Published: (2025-08-01)

Development of a Novel Intraperitoneal Icodextrin/Dextrose Solution for Enhanced Sodium Removal
by: Jennifer L. Asher, et al.
Published: (2025-01-01)

Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases
by: Reetta Peltonen, et al.
Published: (2018-01-01)

XCL1-secreting CEA CAR-T cells enhance endogenous CD8+ T cell responses to tumor neoantigens to confer a long-term antitumor immunity
by: Kun Chen, et al.
Published: (2025-01-01)

Intraoperatively preventive intraperitoneal perfusion chemotherapy with lobaplatin in colorectal cancer: a prospective, randomised, controlled, multicentre study
by: Hao Su, et al.
Published: (2025-06-01)

Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases
by: Raymond Hayler, et al.
Published: (2025-07-01)

Advances in surgical treatment of ulcerative colitis associated colorectal cancer
by: He-Yuan NIU, et al.
Published: (2023-12-01)

The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer
by: Chengxin Luo, et al.
Published: (2017-01-01)

Machine learning-based dynamic CEA trajectory and prognosis in gastric cancer
by: Yonghe Chen, et al.
Published: (2025-07-01)

Microbiota manipulation to increase macrophage IL-10 improves colitis and limits colitis-associated colorectal cancer
by: Daniel F. Zegarra Ruiz, et al.
Published: (2022-12-01)

Treatment-refractory ulcerative colitis responsive to indigo naturalis
by: Berkeley Limketkai, et al.
Published: (2021-10-01)

Uncommon Presentation of Autoimmune Pancreatitis With Refractory Ulcerative Colitis
by: Morgan Starkey, et al.
Published: (2022-06-01)

European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring
by: Biagio De Angelis, et al.
Published: (2025-04-01)